DBVT SEC Filings: 8-K, 10-Q, S-3 & 424B – DBV Technologies

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 28, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Jul 16, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Apr 30, 2026

10-K/A

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Apr 30, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 26, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 28, 2025

News

TYPE

HEADLINE

FILED AT

8-K

DBV Technologies Reports Third Quarter 2026 Financial Results and Business Update

Oct 28, 2026

8-K

DBV Technologies Submits BLA to U.S. FDA for VIASKIN Peanut Patch in Children Aged 4-7 Years

Sep 29, 2026

8-K

DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update

Jul 16, 2026

8-K

DBV Technologies Updates BLA Submission Timeline for VIASKIN® Peanut Patch

Jun 29, 2026

8-K

DBV Technologies Announces 2026 Performance Share Unit Plan for CEO

Jun 5, 2026

8-K

DBV Technologies S.A. Announces Results of Annual General Meeting and Bylaw Amendments

Jun 3, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

September 2025 ATM | Offering amount: $150,000,000

Sep 5, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 289,013,065 | Warrants amount: 254,953,061

May 29, 2025

424B3

UPDATED

Aug 11, 2022

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 59,269,629 | Warrants amount: 28,276,331

Aug 11, 2022

424B5

ATM | Offering amount: $100,000,000

May 2, 2022

424B5

Registration

Jan 30, 2020

Registrations

TYPE

HEADLINE

FILED AT

S-3ASR

July 2026 SHELF + ATM

Jul 27, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 4, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 4, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 24, 2025

S-3

SHARE RESALE REGISTRATION | Shares amount: 289,013,065 | Warrants amount: 195,000,000

May 19, 2025

Form D - Notice of Exempt Offering of Securities - Item 06b

Apr 17, 2025

Proxies

TYPE

HEADLINE

FILED AT

DEF 14A

Form DEF 14A - Other definitive proxy statements

May 11, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

May 1, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

May 15, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

May 5, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 26, 2024

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 8, 2024

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G/A

MPM BioImpact LLC (Filed by)

Aug 14, 2026

SCHEDULE 13G

RA CAPITAL MANAGEMENT, L.P. (Filed by)

Aug 6, 2026

Mohideen Pharis (Reporting)

Jul 31, 2026

SCHEDULE 13G/A

MPM BioImpact LLC (Filed by)

May 15, 2026

SCHEDULE 13G/A

Adage Capital Management, L.P. (Filed by)

May 13, 2026

SCHEDULE 13G/A

Artisan Partners Limited Partnership (Filed by)

May 13, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

May 30, 2025

CORRESP

Form CORRESP - Correspondence

May 27, 2025

LETTER

Form UPLOAD - SEC-generated letter

May 23, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 18, 2023

CORRESP

Form CORRESP - Correspondence

Apr 13, 2023

LETTER

Form UPLOAD - SEC-generated letter

Apr 13, 2023

DBV Technologies S.A. DBVT · SEC Filings